Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,800
+50 (0.36%)
Last updated: Jul 25, 2025
0.36%
Market Cap244.94B
Revenue (ttm)272.12B
Net Income (ttm)11.34B
Shares Out17.97M
EPS (ttm)631.29
PE Ratio21.59
Forward PEn/a
Dividend150.00 (1.09%)
Ex-Dividend DateDec 27, 2024
Volume1,068
Average Volume35,768
Open13,730
Previous Close13,750
Day's Range13,730 - 13,870
52-Week Range9,540 - 15,550
Beta0.69
RSI48.58
Earnings DateAug 13, 2025

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 670
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.